Verdiva Bio is a Biotech company based in London, Country (or null). It has raised $411M in total funding. Latest round: Series A.
Verdiva Bio is a Biotech company based in London, Country (or null). Verdiva Bio has raised $411M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in January 2025. The round record for Verdiva Bio runs through 2025; nothing later has been disclosed. Investors on record include Forbion, General Atlantic, RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
Every Verdiva Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in London at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026